|
|||||
|
|
Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML) |
|
| Authors: | Thorsten Braun |
| Affiliation: | 1. Hematology Department, Avicenne Hospital-Assistance Publique H?pitaux de Paris (AP-HP), University Paris XIII, Bobigny, France;2. Laboratoire de Transfert des Leucémies, Institut Universitaire d’Hématologie, University Paris VII, Paris, France |
| Abstract: | |
| Keywords: | AML BET inhibitors epigenetics c-MYC OTX015 (MK-8628) |